Scarica l'app Stockscreener
3.255
3.01%
0.095
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OM Giù?
Forum
Previsione
Precedente Chiudi:
$3.16
Aprire:
$3.21
Volume 24 ore:
194.14K
Relative Volume:
0.25
Capitalizzazione di mercato:
$59.60M
Reddito:
$114.73M
Utile/perdita netta:
$-140.94M
Rapporto P/E:
-1.1793
EPS:
-2.76
Flusso di cassa netto:
$-126.18M
1 W Prestazione:
+2.36%
1M Prestazione:
-3.98%
6M Prestazione:
-76.22%
1 anno Prestazione:
-60.79%
Intervallo 1D:
$3.1856
$3.4659
Intervallo di 1 settimana:
$3.00
$3.4659
Portata 52W:
$3.00
$21.98
Outset Medical Inc Stock (OM) Company Profile
Nome
Outset Medical Inc
Settore
Industria
Telefono
669-231-8200
Indirizzo
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
3.255 | 59.60M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Iniziato | BTIG Research | Buy |
| 2024-04-05 | Aggiornamento | CL King | Neutral → Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-17 | Iniziato | CL King | Neutral |
| 2022-11-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-07-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Iniziato | Cowen | Outperform |
| 2021-04-19 | Iniziato | Wells Fargo | Overweight |
| 2020-12-16 | Iniziato | Oppenheimer | Perform |
| 2020-10-12 | Iniziato | Barclays | Overweight |
| 2020-10-12 | Iniziato | BofA Securities | Buy |
| 2020-10-12 | Iniziato | Goldman | Buy |
| 2020-10-12 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Outset Medical Inc Borsa (OM) Ultime notizie
Outset Medical (OM) soars 22.2%: Is further upside left in the stock? - MSN
Analyst sentiment on Outset Medical (OM) remains strong following Q4 results - MSN
Outset Medical, Inc. $OM Position Lessened by Pura Vida Investments LLC - MarketBeat
Shorts Report: Is Outset Medical Inc in a bullish channelEarnings Recap Report & Real-Time Volume Surge Alerts - baoquankhu1.vn
OM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FDA Clears Outset Medical’s Next-Generation Hemodialysis System - Medical Product Outsourcing
Outset Medical Earnings Call Highlights Margin Turnaround - TipRanks
Outset Medical webinar spotlights Community Health Systems insourced dialysis expansion - Traders Union
Outset Medical, Inc. (OM) Stock Analysis: A Potential 211% Upside Sparks Investor Interest - DirectorsTalk Interviews
Aug Retail: What is Outset Medical Incs 5 year growth outlookPortfolio Return Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Exit Recap: Can Outset Medical Inc sustain earnings growthForecast Cut & High Yield Stock Recommendations - baoquankhu1.vn
OMOutset Medical, Inc. Latest Stock News & Market Updates - Stock Titan
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results - Yahoo Finance
Outset Medical general counsel Brottem sells $9,520 in stock - Investing.com Nigeria
Leslie Trigg Sells 3,361 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Outset Medical general counsel Brottem sells $9,520 in stock By Investing.com - Investing.com UK
[Form 4] Outset Medical, Inc. Insider Trading Activity - Stock Titan
Outset Medical, Inc. (NASDAQ:OM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
OM (NASDAQ: OM) Form 144: Proposed sale of 9,319 RSU‑settled shares - Stock Titan
Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion - MSN
Outset Medical, Inc. (NASDAQ:OM) Q4 2025 Earnings Call Transcript - Insider Monkey
US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results - Yahoo Finance
RBC Capital Reaffirms Their Hold Rating on Outset Medical (OM) - The Globe and Mail
Outset Medical (NASDAQ:OM) Given New $15.00 Price Target at BTIG Research - MarketBeat
Outset Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Stifel lowers price target on Outset Medical, Inc. (OM) to $8, maintains buy rating - MSN
BTIG Lowers Price Target for Outset Medical (OM) to $15, Maintai - GuruFocus
Outset Medical stock dips on Q4 EPS miss - MassDevice
What’s the fair value of Outset Medical Inc. stockJuly 2025 Spike Watch & Verified Swing Trading Watchlists - mfd.ru
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strate - GuruFocus
Outset Medical: Stabilizing Execution, Improving Margins, and Balanced 2026 Outlook Support Buy Rating Despite Lower Target - TipRanks
Outset Medical Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth By Investing.com - Investing.com Canada
Outset Medical (OM) Sets 2026 Revenue and Margin Targets - GuruFocus
Outset Medical earnings missed by $0.60, revenue fell short of estimates - Investing.com Canada
OM: Revenue up 5% to $119.5M, margin expands, and next-gen Tablo FDA-cleared for 2026 growth - TradingView
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth - Investing.com
Outset Medical Inc. (OM) Misses Q4 EPS by 60c - StreetInsider
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Outset Medical Q4 Earnings Report: What Investors Need to Know - Benzinga
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial ... By GuruFocus - Investing.com Canada
Outset Medical Q4 2025 earnings preview - MSN
Outset Medical Inc (OM) Q4 2025: Everything You Need To Know Ahe - GuruFocus
Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating - Finviz
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
Outset Medical Secures Key FDA Clearance for Next-Generation Dialysis System - AD HOC NEWS
Outset Medical (NASDAQ:OM) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Outset Medical, Inc. (OM) Stock Analysis: Exploring A 139.80% Potential Upside - DirectorsTalk Interviews
Outset Medical (OM) to Release Quarterly Earnings on Wednesday - MarketBeat
Outset Medical Inc Azioni (OM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):